"Watchful Waiting" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Clinical management approach wherein immediate therapy is not provided but there is a period of observation during which periodic tests monitor patient and the progression of the illness. (Driffield T, Smith PC Med Decis Making. 2007 Mar-Apr;27(2):178-88)
| Descriptor ID |
D057832
|
| MeSH Number(s) |
N04.761.559.590.900
|
| Concept/Terms |
Watchful Waiting- Watchful Waiting
- Waiting, Watchful
- Waitings, Watchful
- Watchful Waitings
|
Below are MeSH descriptors whose meaning is more general than "Watchful Waiting".
Below are MeSH descriptors whose meaning is more specific than "Watchful Waiting".
This graph shows the total number of publications written about "Watchful Waiting" by people in this website by year, and whether "Watchful Waiting" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 1 | 2 |
| 2012 | 1 | 1 | 2 |
| 2013 | 2 | 4 | 6 |
| 2014 | 4 | 1 | 5 |
| 2015 | 5 | 4 | 9 |
| 2016 | 2 | 1 | 3 |
| 2017 | 2 | 1 | 3 |
| 2018 | 1 | 4 | 5 |
| 2019 | 2 | 2 | 4 |
| 2020 | 1 | 0 | 1 |
| 2021 | 5 | 2 | 7 |
| 2022 | 1 | 7 | 8 |
| 2023 | 1 | 1 | 2 |
| 2024 | 2 | 3 | 5 |
| 2025 | 3 | 1 | 4 |
| 2026 | 3 | 1 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Watchful Waiting" by people in Profiles.
-
Crizotinib versus observation or placebo for surgically resected early-stage ALK-positive non-small-cell lung cancer (Eastern Cooperative Oncology Group-American College of Radiology Imaging Network E4512): a phase 3 trial. Lancet Respir Med. 2026 Nov; 14(11):972-982.
-
Adjuvant Nivolumab vs Observation in Resected Non-Small Cell Lung Cancer: A Randomized Clinical Trial. JAMA. 2026 Aug 11; 336(6):464-472.
-
A multilevel intervention to improve adherence to prostate cancer active surveillance versus usual care: results from a pilot randomized controlled trial. BMC Cancer. 2026 Jul 29; 26(1).
-
Aquablation for LUTS due to BPH in men with localized prostate cancer. Can J Urol. 2026 Jun 26; 33(3):555-562.
-
Utilizing Patient Input in Rectal Cancer Trial Design. J Natl Cancer Inst. 2025 Jul 01; 117(7):1421-1428.
-
Routine prostate biopsies not needed after cryotherapy if surveillance MRI is normal. BJU Int. 2025 Sep; 136(3):447-451.
-
Projected outcomes of reduced-biopsy management of Grade Group 1 prostate cancer: implications for relabeling. J Natl Cancer Inst. 2025 Apr 01; 117(4):685-691.
-
Multi-level Factors to Build Confidence and Support in Active Surveillance for Low-Risk Prostate Cancer: A Qualitative Study. J Gen Intern Med. 2025 04; 40(5):1107-1115.
-
Management of monochorionic diamniotic twin gestation affected by Type-II selective fetal growth restriction: cost-effectiveness analysis. Ultrasound Obstet Gynecol. 2025 01; 65(1):39-46.
-
Proportion of Patients With Ductal Carcinoma In Situ That Qualify for Observation Criteria Set Forth by Clinical Trials. J Surg Oncol. 2025 Feb; 131(2):115-123.